Predicting circulating CA125 levels among healthy premenopausal women

BACKGROUND: CA125 is the most promising ovarian cancer screening biomarker to date. Multiple studies reported CA125 levels vary by personal characteristics, which could inform personalized CA125 thresholds. However, this has not been well described in premenopausal women. METHODS: We evaluated predi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Epidemiol Biomarkers Prev
Main Authors: Sasamoto, Naoko, Babic, Ana, Rosner, Bernard A., Fortner, Renée T., Vitonis, Allison F., Yamamoto, Hidemi, Fichorova, Raina N., Tjønneland, Anne, Hansen, Louise, Overvad, Kim, Kvaskoff, Marina, Fournier, Agnès, Romana Mancini, Francesca, Boeing, Heiner, Trichopoulou, Antonia, Peppa, Eleni, Karakatsani, Anna, Palli, Domenico, Pala, Valeria, Mattiello, Amalia, Tumino, Rosario, Grasso, Chiara C., Onland-Moret, N. Charlotte, Weiderpass, Elisabete, Quirós, J. Ramón, Lujan-Barroso, Leila, Rodríguez-Barranco, Miguel, Colorado-Yohar, Sandra, Barricarte, Aurelio, Dorronsoro, Miren, Idahl, Annika, Lundin, Eva, Sartor, Hanna, Khaw, Kay-Tee, Key, Timothy J, Muller, David, Riboli, Elio, Gunter, Marc J., Dossus, Laure, Kaaks, Rudolf, Cramer, Daniel W., Tworoger, Shelley S., Terry, Kathryn L.
Formato: Artigo
Idioma:Inglês
Publicado: 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6548604/
https://ncbi.nlm.nih.gov/pubmed/30948451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-18-1120
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares